Targeting ERBB2 (HER2) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional Indications

Web

Nov. 4, 2019

SCIENTIFIC

A small basket study has suggested efficacy for ERBB2 targeted therapy in patients with ERBB2-amplified tumours outside of approved indications.

https://ascopubs.org/doi/full/10.1200/PO.18.00345